glp-1 weight-loss drugs
Choosing Semaglutide Saves 30% Weight‑Gain Risk
Choosing semaglutide reduces the risk of weight regain by roughly 30% compared with other GLP-1 agonists, making it the safer first-line option for most patients. The drug’s slower taper and lower nausea profile keep patients on therapy longer, which is the key to sustained loss. Medical Disclaimer: This article